Dental KOL Call: Healthy Implant Growth; Solid Aligner Growth; +ALGN Share

Research evidence excerpt

Dental KOL Call: Healthy Implant Growth; Solid Aligner Growth; +ALGN Share

Expert

Series

USA | Medical Supplies & Devices EquityJuneResearch9, 2026

Dental KOL Call: Healthy Implant Growth; Solid

Aligner Growth; +ALGN Share

Key Takes from our KOL call with Dr. Marcos Magar, dentist: 1/ Implant demand

accelerating as better-informed patients favouring LT solutions. 2/ Pricing

still key constraint vs bridges. 3/ Clear aligners growing (~20% yoy). 4/ Mix

.

volatile, driven by geo + strong Invisalign brand pull. 5/ Limited cost delta (~

$300) supports pricing dispersion. 6/ Digital fully embedded. 7/ Tech adoption

selective, constrained by ROI & workflow stickiness.

Implants accelerating as patients shift to long-term solutions. Patient behaviour has shifted over

~24m, driven by stronger education (web, peers). Decision-making is now more LT-focused, with

patients increasingly favouring implants vs restorations. Rising scepticism on crowns/root canals

(durability, cumulative cost) is pushing more patients toward full rehab decisions. Demand remains

geo-divergent, with affordability still a constraint. Implants remain a premium option vs bridges.

Implants are becoming the Standard of Care. This is driven by rising patient awareness of their LT

value vs restorative work. The KOL is seeing rapid volume growth in his practices (~150 implants

in '26, potentially doubling YoY). While Dr. Magar narrows the pricing gap vs bridges, pricing

remains a barrier to adoption (~$4k vs ~$3.6–3.8k bridge) alongside patient suitability, despite

more conservative clinical benefits.

Dr. Magar sees STMN & Nobel as preferred implant manufacturers. Our KOL relies on Nobel

(~75%) and STMN (~25% / mainly BLT), with the latter more expensive ($200-250/implant vs ~

$100–150).